Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis. FE 2018, 19 (1). https://doi.org/10.7175/fe.v19i1.1385.